Back to Journals

Infection and Drug Resistance


Aims and Scope

Editor-in-Chief: Professor Suresh Antony

Infection and Drug Resistance is an international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance. 

The journal is characterized by the rapid reporting of high-quality original research, reviews, guidelines, expert opinions, commentary and clinical studies in all areas of infection and drug resistance. Specific topics covered by the journal include: 

  • Development of novel anti-infectives
  • Optimal use of existing anti-infectives
  • Pathogenesis and etiology of infectious disease
  • Proteomic and genomic studies in resistant organisms
  • Mechanisms of resistance development
  • Infection control in hospitals and the community
  • Diagnosis and early detection of infection
  • Clinical management of infection
  • Clinical management of antibiotic resistance (e.g. in transplant and HIV patients)
  • Epidemiology of infection and antibiotic resistance
  • Education and prevention of drug resistance
  • Patient adherence and satisfaction

The journal does not accept study protocols. The journal will consider case reports only if they make a valuable and original contribution to the literature.

When considering submission of a paper utilizing publicly-available data authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors’ own data through replication in an original sample.

As of 1st April 2019, Infection and Drug Resistance will no longer consider meta-analyses for publication.